+7 (701) 759 90 19
USD 426.01 EUR 493.75
RUB 6.05 CNY 66.62
News

Kazakhstan to produce its QazVac COVID-19 vaccine adapted to Delta strain in October

27 September 2021 19:32
Share in:
Kazakhstan to produce its QazVac COVID-19 vaccine adapted to Delta strain in October

NUR-SULTAN. KAZINFORM – Kazakh Deputy Prime Minister Yeraly Tugzhanov talked about the effectiveness of the Kazakh QazVac COVID-19 vaccine against the highly contagious Delta coronavirus variant, Kazinform correspondent reports.

Related news
4 regions of Kazakhstan remain in COVID-19 ‘red zone’ Coronavirus caseload in Kazakhstan climbs to 934,387 COVID-19 kills 197 more Iranians over past 24 hours

At the press conference at the Government, Mr. Tugzhanov noted that the studies conducted demonstrated that QazVac is affective against the Delta variant. He went on to say that the National Scientific Research Institute for Biological Safety Problems did considerable work to change the Wuhan coronavirus strain to the Delta strain in the QazVac vaccine, which will be available this October.

According to the Deputy PM, the National Scientific Research Institute for Biological Safety Problems isolated the pathological material from the Eta strain and plans to study it in the next two weeks.

«The effectiveness of QazVac against the Eta strain will be assessed,» he said, noting that the Institute takes proactive measures to make sure the population is protected and safe.

Earlier he noted that deliveries of the US’s Pfizer vaccine are expected in the fourth quarter of the year.



Share in:

Author:

Adlet Seilkhanov

Related news
Read also
+7
Send
Employees online
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048

Archive